🔗 Share this article

An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Investigational Drug Acquiring Traction Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Followers are urged to message these accounts directly for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day British shipping. Sellers market the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Voice Worries

Nevertheless, doctors and chemists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.

Some professionals said the popularity for the experimental drug could be linked to the increasing price of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Material Elimination

Based on TikTok, the platform has taken down problematic material and prohibited related hashtags and query recommendations. The organization said it was dedicated to keeping the platform safe and allocating resources in enhancing enforcement strategies.

Digital Trading Operations

Investigations also found groups with up to nine thousand members selling retatrutide using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, populated with images of weight loss, glowing testimonials and detailed guides for mixing or administering at residence.

After moments of entering one group, a vendor shared contact information, where the majority of transactions occur. The vendor provided an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, health issues or previous experience.

Product Details and Pricing

Within these groups, messages display black plastic parcels with Royal Mail labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with sterile water, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When asked how long a pen should be used, sellers give conflicting answers varying between a several days to “depends on your body”.

Service Oversight and Security Measures

A representative for Telegram stated it regularly moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting materials they can’t verify. Although the research behind retatrutide is valid, these digital versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current price rises for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.

Her team has previously encountered individuals harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company investigational product not yet approved … may subject patients to potentially serious medical dangers”.